IL2401

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameIL2401
Drug Alias NameIL2401IL-2401
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody degrader conjugate
Mechanisms of ActionAnti-Trop-2Cyclin-K degraders
TargetsTumor-associated calcium signal transducer 2Cyclin-K
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiLeadBMS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiLeadBMS Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A